Merck CEO, Robert Davis, joins “Sabah with Maria” to discuss a billion billion dollars of new biology manufacturing facility.
Thousands of jobs It can be on the horizon of American workers, where the Merck drug manufacturer takes steps to transfer manufacturing to the United States, especially in the form of a billion billion dollar biological center under construction in Wilmengton, Dilayer.
At Fox Business Exclusive, the CEO of the company Robert Davis told “Mornings with Maria” will take time because Merck builds the ability, but the reward may mean stable access to drugs in addition to high wage jobs.
Davis said Merck is currently making a contract with drugs in the United States as well as outside the United States, but the company is looking to have both materials and producer in the United States
A man from India was arrested in Texas for allegedly selling fake cancer medications to people in us
Signs outside MERCK headquarters in Kenilworth, New Jersey, United States, on Monday, January 25, 2021. (Christopher Okchicone / Bloomberg / Getty EM.
“For Ireland, what this means is not necessarily that we will close the operations, because we still have to serve the rest of the world as well,” I explained on Tuesday.
“This is really an opportunity for us (we have) the United States (saving) for (The) US, (and) Europe (saving) for Europe, and we have more risks and flexibility Suppliers This has an option that allows us to bring security. While we think about national security, this is an important security for drug supply in the United States so that we can make sure that regardless of the situation, patients can reach medicine. “
How can Trump’s tariff affect the labor market
MERCK manufactures folk medicines such as Keytruda, an immunotherapy drug used to treat cancer. (Lindsey Nicholson/UCG/Universal Images Getty Images/Getty Images)
A press release From the United States, Merck Wilmington Biotech will include “laboratory, manufacturing and warehouse capabilities to enable the launch and production of biology from the next generation and treatments including ADCS, which enhances Merck’s focus on expanding and diversifying his pipeline.”
The site will also have the production capabilities of the famous immunotherapy Keytruda, which is used to treat cancer.
Click here to get Fox Business on
President Trump accused Ireland of luring the American pharmaceutical companies, as he obtained revenues and jobs from the United States due to the low corporate tax rate.
Davis said the site can initially provide 4000 construction jobs and 500 full -time jobs, but expanded to a workforce of 2000 construction workers.
“It will be a significant opportunity for merchants and manufacturing for good quality jobs here in the United States,” he added.
https://a57.foxnews.com/static.foxbusiness.com/foxbusiness.com/content/uploads/2025/04/0/0/gettyimages-1230787969-scaled.jpg?ve=1&tl=1
Source link